Dr. Gibson is currently Associate Dean of Faculty Affairs, Professor of Pathology, Chair of the Department of Clinical Sciences, and Director of Molecular Diagnostics at the University of Central Florida College of Medicine. She is board certified by the American Board of Medical Genetics and Genomics (ABMGG), is a fellow of the American College of Medical Genetics (ACMG), and serves as a member of the American Board of Medical Genetics and Genomics Board of Directors. Dr. Gibson received her training at the University of Florida College of Medicine, and her practice includes molecular pathology and molecular genetics.  She has served as the Director of Molecular Genetics for M.D. Anderson Cancer Center Orlando, and later as the  Director of Molecular Genetics and Cytogenetics for AmeriPath, Inc. (A Division of  Quest Diagnostics).  She participates in a number of national-level professional activities including serving as Chair of the Association for Molecular Pathology (AMP) Publications and Communications Committee and member of the AMP Board of Directors. She is on the editorial board for the Journal of Molecular Diagnostics, and has authored a number of book chapters, articles and published abstracts in the fields of molecular pathology and genetics, and has been the principle investigator for numerous clinical trials.

Publications

Sarosdy, M., Kahn, P. Ziffer M., Love, W., Barkin J., Abara, E. Jansz, K., Bridge, J., Johansson, S., Persons, D., and Gibson, J. Use of a mutitarget fluorescence in situ hybridization assay to diagnose bladder cancer in patients with hematuria J Urol 2006 Jul;176(1):44-7 Gibson, J.S., et al. The Roche AMPLICOR HPV Test as a primary screen for HPV in cervical specimens collected in ThinPrep and SurePath liquid cytology media. 21st International Papilloma Conference Proceedings 2004: 261

Gibson, J.S. Vinson, D., Flynn, D., Hernandez S., Bolick, D., Juretich, M., Kosarikov, D., Bui, L., and Sun, R. Evaluation Of The Roche Prototype Line-Blot (LBA) Assay For Detection And Genotyping Of High-Risk HPV From Specimens Collected In Sure-Path and Thin-Prep Liquid Cytology Medias. American Society of Cytopathology Annual Meeting, November 2003.

Chakrabarti, R., Robles, L.D., Gibson, J., and Muroski, M. Profiling Of Differential Expression Of Messenger RNA In Normal, Benign, And Metastatic Prostate Cell Lines. Cancer Genet Cytogenet. 139: 115-25, 2002.